Changes in Cognitive Function in Older Women With Breast Cancer Treated with Standard Chemotherapy and Capecitabine within CALGB 49907

被引:1
|
作者
Freedman, R. A.
Pitcher, B.
Keating, N. L.
Barry, W. T.
Balman, K. V.
Kornblith, A.
Mandelblatt, J.
Kimmick, G. G.
Hurria, A.
Winer, E. P.
Hudis, C. A.
Cohen, H. J.
Muss, H. B.
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Mayo Clin, Rochester, MN USA
[5] Georgetown Univ, Washington, DC USA
[6] City Hope Natl Med Ctr, Duarte, CA USA
[7] Mem Sloan Kettering, New York, NY USA
[8] Univ N Carolina, Chapel Hill, NC USA
关键词
D O I
10.1158/0008-5472.SABCS12-P6-08-05
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P6-08-05
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907
    Freedman, Rachel A.
    Pitcher, Brandelyn
    Keating, Nancy L.
    Ballman, Karla V.
    Mandelblatt, Jeanne
    Kornblith, Alice B.
    Kimmick, Gretchen G.
    Hurria, Arti
    Winer, Eric P.
    Hudis, Clifford A.
    Cohen, Harvey Jay
    Muss, Hyman B.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) : 607 - 616
  • [2] Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907
    Rachel A. Freedman
    Brandelyn Pitcher
    Nancy L. Keating
    Karla V. Ballman
    Jeanne Mandelblatt
    Alice B. Kornblith
    Gretchen G. Kimmick
    Arti Hurria
    Eric P. Winer
    Clifford A. Hudis
    Harvey Jay Cohen
    Hyman B. Muss
    Breast Cancer Research and Treatment, 2013, 139 : 607 - 616
  • [3] CALGB 60104: Adherence with adjuvant capecitabine among women age 65 and older with early stage breast cancer treated on CALGB 49907
    Partridge, A. H.
    Archer, L. E.
    Kornblith, A. B.
    Gralow, J. R.
    Grenier, D.
    Perez, E. A.
    Wolff, A. C.
    Hudis, C. A.
    Winer, E. P.
    Muss, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] Standard chemotherapy versus capcitabine for older women with early stage breast cancer: An update of CALGB/CTSU/Alliance 49907
    Muss, Hyman B.
    Berry, Donald A.
    Cirrincione, Constance T.
    Theodoulou, Maria
    Hurria, Arti
    Cohen, Harvey Jay
    Partridge, Ann
    Norton, Larry
    Hudis, Clifford A.
    Winer, Eric P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial
    Muss, Hyman B.
    Polley, Mei-Yin C.
    Berry, Donald A.
    Liu, Heshan
    Cirrincione, Constance T.
    Theodoulou, Maria
    Mauer, Ann M.
    Kornblith, Alice B.
    Partridge, Ann H.
    Dressler, Lynn G.
    Cohen, Harvey J.
    Kartcheske, Patricia A.
    Perez, Edith A.
    Wolff, Antonio C.
    Gralow, Julie R.
    Burstein, Harold J.
    Mahmood, Ahmad A.
    Sutton, Linda M.
    Magrinat, Gustav
    Parker, Barbara A.
    Hart, Ronald D.
    Grenier, Debjani
    Hurria, Arti
    Jatoi, Aminah
    Norton, Larry
    Hudis, Clifford A.
    Winer, Eric P.
    Carey, Lisa
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (26) : 2338 - +
  • [6] Standard chemotherapy (CMF or AC) versus capecitabine in early-stage breast cancer (BC) patients aged 65 and older: Results of CALGB/CTSU 49907
    Muss, H. B.
    Berry, D. L.
    Cirrincione, C.
    Theodoulou, M.
    Mauer, A.
    Cohen, H.
    Partridge, A. H.
    Norton, L.
    Hudis, C. A.
    Winer, E. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [7] Comorbidity, Chemotherapy Toxicity, and Outcomes Among Older Women Receiving Adjuvant Chemotherapy for Breast Cancer on a Clinical Trial: CALGB 49907 and CALGB 361004 (Alliance)
    Klepin, Heidi D.
    Pitcher, Brandelyn N.
    Ballman, Karla V.
    Kornblith, Alice B.
    Hurria, Arti
    Winer, Eric P.
    Hudis, Clifford
    Cohen, Harvey J.
    Muss, Hyman B.
    Kimmick, Gretchen G.
    JOURNAL OF ONCOLOGY PRACTICE, 2014, 10 (05) : E285 - E292
  • [8] Quality of Life of Early Stage Breast Cancer Patients 65 Years Old or Older Randomized to Standard Chemotherapy or Capecitabine: A Cancer and Leukemia Group B Study (CALGB 49907).
    Kornblith, A. B.
    Archer, L.
    Lan, L.
    Kimmick, G.
    Partridge, A.
    Casey, R.
    Bennett, S.
    Hudis, C.
    Winer, E.
    Cohen, H. J.
    Muss, H. B.
    CANCER RESEARCH, 2009, 69 (24) : 776S - 776S
  • [9] The preference to receive chemotherapy and cancer-related outcomes in older adults with breast cancer CALGB 49907 (Alliance)
    Gajra, Ajeet
    McCall, Linda
    Muss, Hyman B.
    Cohen, Harvey J.
    Jatoi, Aminah
    Ballman, Karla V.
    Partridge, Ann H.
    Sutton, Linda
    Parker, Barbara A.
    Magrinat, Gustav
    Klepin, Heidi D.
    Lafky, Jacqueline M.
    Hurria, Arti
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (03) : 221 - 227
  • [10] Adherence and Persistence With Oral Adjuvant Chemotherapy in Older Women With Early-Stage Breast Cancer in CALGB 49907: Adherence Companion Study 60104
    Partridge, Ann H.
    Archer, Laura
    Kornblith, Alice B.
    Gralow, Julie
    Grenier, Debjani
    Perez, Edith
    Wolff, Antonio C.
    Wang, Xiaofei
    Kastrissios, Helen
    Berry, Donald
    Hudis, Clifford
    Winer, Eric
    Muss, Hyman
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (14) : 2418 - 2422